Hillsdale Investment Management Inc. Assembly Biosciences, Inc. Transaction History

Hillsdale Investment Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$4.87 - $17.29 $183,599 - $651,833	-37,700 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$15.08 - $27.04 $568,516 - $1.02 Million	37,700 New	37,700 $620,000
Q2 2018 Aug 13, 2018	SELL	$39.21 - $50.29 $74,499 - $95,551	-1,900 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$41.7 - $64.16 $16,680 - $25,664	400 Added 26.67%	1,900 $93,000
Q4 2017 Feb 13, 2018	BUY	$28.58 - $49.91 $42,870 - $74,865	1,500	1,500 $68,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.